Med-X-Press GmbH

Blog #13: Chat GPT: curse or blessing?

Natascha de Raad on the experiences, concerns and opportunities of ChatGPT

Natascha de Raad on the experiences, concerns and opportunities of ChatGPT

By Natascha de Raad
reading time: 4 Minutes
 

Over the weekend, I did what many people around me and elsewhere in the world are doing right now. I communicated with ChatGPT and asked them to write a short presentation for me on the future of pharma logistics. You can read about what AI has put "on paper" and my comments in today's BLOG 13. 

Here are the task and the answer: 

Today I would like to give you a short presentation on the future of pharmaceutical logistics.
Pharmaceutical logistics is facing major challenges in a rapidly changing world. The growing demand for pharmaceuticals, increasing globalization and rising demands on the safety and quality of products are presenting the industry with ever greater logistical challenges.

One of the biggest changes in pharmaceutical logistics will be advancing digitalization. Modern technologies such as the Internet of Things, big data analytics and artificial intelligence will play an increasingly important role in the future and enable better transparency and efficiency in the supply chain. This will make it possible to automate processes and introduce real-time tracking systems that will make the transportation of pharmaceuticals more reliable and faster.

Another important aspect of future pharmaceutical logistics is the development of new means of transportation. Drones, autonomous vehicles and intelligent transportation systems will play a greater role in the future and improve the efficiency and flexibility of the supply chain. It will also be possible to make the transportation of pharmaceuticals more climate-friendly and sustainable.

Another important trend in pharmaceutical logistics is personalization. More and more medicines are being tailored to the individual needs of patients. As a result, it will be necessary to make the supply chain more flexible and faster in order to enable the delivery of personalized medicines.

In summary, it can be said that the future of pharmaceutical logistics will be shaped by advancing digitalization, the development of new means of transport and the personalization of medicines. Companies that rise to these challenges and optimize their logistics and supply chain processes accordingly will remain competitive in the future and be better able to meet the needs of their customers.

Thank you for your attention. 

Chapeau! In terms of content, I would also have addressed these points. Admittedly, there is room for improvement in terms of style, especially when speaking in front of an audience - but no problem. The factors listed get to the heart of the matter and that's what counts. In any case, I found this first experience with the dialog-based chatbot fascinating.  If you are one of those who have already completed this test phase, then you have experienced how the text is produced line by line before your very eyes - faster than we can think. If necessary, you can criticize in the chat and the AI regrets having let you down. It sounds like a gimmick, but it will seriously change our everyday lives. 

Two general comments on this: 

  1. inevitably these thoughts and questions arise: "What does this mean for the future of work, in schools, in care or other areas of society?"  I think AI, and in this case the chatbot, should replace human activity where it makes sense and has a positive impact. That sounds general, but in concrete terms I can imagine, for example, the package leaflet for medicines or the instructions for use for technical devices being created using AI. What I cannot and do not want to imagine is AI replacing people and their creativity. Even if it is capable of learning, we should draw boundaries where thinking, feeling and personal, informal encounters play a role. This is also the focus of the German Ethics Council's statement that the use of AI applications should expand human development and not diminish it. Artificial intelligence must not replace humans with machines. 
     
  2. And this is the second point that is important to me. We need clear rules for dealing with AI. I find the reactions to the hype surrounding ChatGPT very amusing, but it annoys me when I read the headline: "Culture ministers in a state of shock". This suggests that AI is a sudden phenomenon that is sweeping classrooms unbidden. We have all been using the convenience of navigation systems for years, which use AI to guide us unerringly to the location we enter - at least most of the time. Many other functions are familiar to us in everyday life. But, regardless of the application: We should write rules as soon as possible - and there is a considerable need for regulation - for example with texts. "What about copyright or the distribution of text material?" I am clearly an advocate of reducing bureaucracy, and not just in the pharmaceutical sector. Just think of the sometimes absurd effects of the GDPR that we are forced to deal with. But where it is necessary - and I include AI in this - we need rules. As in many other areas of digitalization, we must not oversleep this development again! In the meantime, we can ask the chatbot how we can best keep this technology in check. 

 

I am very interested in your opinion on this topic. Do you have positive, negative or any experience at all with ChatGPT. Let's have a personal exchange and talk about it. I look forward to your feedback and the start of a lively discussion. I look forward to your feedback!

Get in touch with suggestions or criticism:  blog@med-x-press.de